Figure 3From: Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemiaThe diagnostic capability of each peak in QC model determined by ROC curve. A. Area under the curve (AUC) of the peptide with MW of 2661.27 Da is 92.56%, representing higher diagnostic value. B.AUC of the peptide with MW of 2991.46 Da is 89.22%, representing moderate diagnostic value. C. AUC of the peptide with MW of 3443.92 Da is 91%, representing higher diagnostic value. D. AUC of the peptide with MW of 7764.29 Da is 86.56%, representing moderate diagnostic value. E. AUC of the peptide with MW of 9288.31 Da is 90.22%, representing higher diagnostic value.Back to article page